Prevention of chemotherapy-induced ovarian damage

被引:105
作者
Roness, Hadassa [1 ]
Kashi, Oren [1 ]
Meirow, Dror [1 ]
机构
[1] Chaim Sheba Med Ctr, Ctr Fertil Preservat, IL-52621 Tel Hashomer, Israel
关键词
Fertility preservation; chemotherapy; follicle activation; COLONY-STIMULATING FACTOR; ANTI-MULLERIAN HORMONE; PROTECTS MOUSE OOCYTES; ABL TYROSINE KINASE; FERTILITY PRESERVATION; INDUCED APOPTOSIS; GNRH AGONIST; DNA-DAMAGE; C-ABL; TISSUE CRYOPRESERVATION;
D O I
10.1016/j.fertnstert.2015.11.043
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Recent advances in our understanding of the mechanisms underlying the impact of cytotoxic drugs on the ovary have opened up new directions for the protection of the ovary from chemotherapy-induced damage. These advances have spurred the investigation of pharmacological agents to prevent ovarian damage at the time of treatment. Prevention of ovarian damage and follicle loss would provide significant advantages over existing fertility preservation techniques. This manuscript reviews new methods for the prevention of chemotherapy-induced ovarian damage, including agents that act on the PI3K/PTEN/Akt follicle activation pathway, apoptotic pathways, the vascular system, and other potential methods of reducing chemotherapy-induced ovotoxicity. (C) 2016 by American Society for Reproductive Medicine.
引用
收藏
页码:20 / 29
页数:10
相关论文
共 101 条
  • [1] Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles
    Adhikari, Deepak
    Liu, Kui
    [J]. ENDOCRINE REVIEWS, 2009, 30 (05) : 438 - 464
  • [2] Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo
    Ahn, Richard W.
    Barrett, Susan L.
    Raja, Meera R.
    Jozefik, Jennifer K.
    Spaho, Lidia
    Chen, Haimei
    Bally, Marcel B.
    Mazar, Andrew P.
    Avram, Michael J.
    Winter, Jane N.
    Gordon, Leo I.
    Shea, Lonnie D.
    O'Halloran, Thomas V.
    Woodruff, Teresa K.
    [J]. PLOS ONE, 2013, 8 (03):
  • [3] Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model
    Akdemir, Ali
    Zeybek, Burak
    Akman, Levent
    Ergenoglu, Ahment Mete
    Yeniel, Ahmet Ozgur
    Erbas, Oytun
    Yavasoglu, Altug
    Terek, Mustafa Cosan
    Taskiran, Dilek
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2014, 25 (04) : 328 - 333
  • [5] [Anonymous], SCI TRANSL MED, DOI DOI 10.1126/SCITRANSLMED.3005402)
  • [6] [Anonymous], ESHRE ANN M LISB POR
  • [7] LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST INHIBITS CYCLOPHOSPHAMIDE-INDUCED OVARIAN FOLLICULAR DEPLETION IN RHESUS-MONKEYS
    ATAYA, K
    RAO, LV
    LAWRENCE, E
    KIMMEL, R
    [J]. BIOLOGY OF REPRODUCTION, 1995, 52 (02) : 365 - 372
  • [8] RETRACTED: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study (Retracted article. See vol. 120, pg. 395, 2023)
    Badawy, Ahmed
    Elnashar, Aboubakr
    El-Ashry, Mohamed
    Shahat, May
    [J]. FERTILITY AND STERILITY, 2009, 91 (03) : 694 - 697
  • [9] In vivo Bioimaging as a Novel Strategy to Detect Doxorubicin-Induced Damage to Gonadal Blood Vessels
    Bar-Joseph, Hadas
    Ben-Aharon, Irit
    Tzabari, Moran
    Tsarfaty, Galia
    Stemmer, Salomon M.
    Shalgi, Ruth
    [J]. PLOS ONE, 2011, 6 (09):
  • [10] Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes
    Bar-Joseph, Hadas
    Ben-Aharon, Irit
    Rizel, Shulamith
    Stemmer, Salomon M.
    Tzabari, Moran
    Shalgi, Ruth
    [J]. REPRODUCTIVE TOXICOLOGY, 2010, 30 (04) : 566 - 572